Marcia Kean, M.B.A., Feinstein Kean Healthcare
Marcia Kean has built Feinstein Kean Healthcare’s unique national role in the life sciences since the firm’s inception twenty five years ago. She served as the Chief Executive Officer of the firm from 2002 to 2011 before becoming Chairman.
Marcia has more than 35 years of biomedical industry experience. She has operating experience inside commercial and non-profit organizations, as well as knowledge of the development and implementation of public-private projects undertaken by multi-stakeholder ecosystems.
In 2004, Marcia founded the first Molecular Medicine communications practice in the country. Marcia has served as an advisor to the Personalized Medicine Coalition (PMC) since its inception, and received that organization’s first Distinguished Service award in 2006. She served in 2006 as a member of the Personalized Health Care Expert Panel convened by the Office of the Assistant Secretary for Planning and Evaluation (ASPE) of the U.S. Department of Health and Human Services, to explore factors related to the integration of personalized health care into clinical and public health practice. She has served as a member of the Evidence Communication Innovation Collaborative of the Institute of Medicine since 2008. She served as co-Vice Chair of the Advisory Committee of the Institute of Medicine’s Cancer Informatics Workshop held in February 2012; as well as serving as lead author of the Discussion Paper used to frame that event, and presenter of the concept of a new coalition in the cancer community to advance data liquidity and thereby enable personalized medicine. She has served as a member of Harvard Personalized Medicine Conference advisory committee since its inception. She is a frequent speaker at industry events, including Bio-IT World, Internet 2, and the Consumer Genetics Conference in Boston.
Marcia holds an M.B.A. in finance from New York University and a B.A. from the University of California at Berkeley.